Amanda R Patrick
Overview
Explore the profile of Amanda R Patrick including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
2127
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jaksa A, Gibbs L, Kent S, Rowark S, Duffield S, Sharma M, et al.
BMJ Open
. 2022 Oct;
12(10):e064662.
PMID: 36253039
Objective: To compare real-world effectiveness and safety of direct oral anticoagulants (DOACs) in patients with nonvalvular atrial fibrillation (AFib) for prevention of stroke. Study Design And Setting: A comparative cohort...
2.
Jaksa A, Bloudek L, Carlson J, Shah K, Chen Y, Patrick A, et al.
Int J Technol Assess Health Care
. 2022 Mar;
38(1):e32.
PMID: 35357284
Health technology assessment (HTA) agencies are considering adopting a lifecycle approach to assessments to address uncertainties in the evidence base at launch and to revisit the clinical and economic value...
3.
Rassen J, Bartels D, Schneeweiss S, Patrick A, Murk W
Clin Epidemiol
. 2018 Dec;
11:1-15.
PMID: 30588119
Background: Health care databases are natural sources for estimating prevalence and incidence of chronic conditions, but substantial variation in estimates limits their interpretability and utility. We evaluated the effects of...
4.
Patorno E, Garry E, Patrick A, Schneeweiss S, Gillet V, Zorina O, et al.
Drug Saf
. 2015 Mar;
38(3):295-310.
PMID: 25761856
A growing body of observational literature on the association between glucose-lowering treatments and all-cause mortality has been accumulating in recent years. However, many investigations present designs or analyses that inadequately...
5.
Patorno E, Patrick A, Garry E, Schneeweiss S, Gillet V, Bartels D, et al.
Diabetologia
. 2014 Sep;
57(11):2237-50.
PMID: 25212258
Background: Recent years have witnessed a growing body of observational literature on the association between glucose-lowering treatments and cardiovascular disease. However, many of the studies are based on designs or...
6.
Gagne J, Rassen J, Choudhry N, Bohn R, Patrick A, Sridhar G, et al.
Drug Saf
. 2014 Feb;
37(3):151-61.
PMID: 24510605
Background: Methods for near-real-time monitoring of new drugs in electronic healthcare data are needed. Objective: In a novel application, we prospectively monitored ischemic, bleeding, and mortality outcomes among patients initiating...
7.
Solomon D, Patrick A, Schousboe J, Losina E
J Bone Miner Res
. 2014 Jan;
29(7):1667-74.
PMID: 24443384
Fractures related to osteoporosis are associated with $20 billion in cost in the United States, with the majority of cost born by federal health-care programs, such as Medicare and Medicaid....
8.
Canestaro W, Patrick A, Avorn J, Ito K, Matlin O, Brennan T, et al.
Circ Cardiovasc Qual Outcomes
. 2013 Nov;
6(6):724-31.
PMID: 24221832
Background: New anticoagulants may improve health outcomes in patients with atrial fibrillation, but it is unclear whether their use is cost-effective. Methods And Results: A Markov state transition was created...
9.
Patrick A, Fischer M, Choudhry N, Shrank W, Seeger J, Liu J, et al.
J Gen Intern Med
. 2013 Oct;
29(2):320-7.
PMID: 24101534
Background: Many patients with type 2 diabetes eventually require insulin, yet little is known about the patterns and quality of pharmacologic care received following insulin initiation. Guidelines from the American...
10.
Patrick A, Franklin J, Weinstein M, Glynn R, Schneeweiss S
Med Decis Making
. 2013 Aug;
33(7):949-60.
PMID: 23920434
Background: Key to conducting active drug safety surveillance using longitudinal health care data is determining whether and when there is sufficient evidence to raise a safety alert. We propose to...